Viridian Therapeutics, Inc.

... ...
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 12.20%147.000.0%$2706.27m
BNGOBioNano Genomics, Inc. 28.37%12.580.0%$2680.39m
GILDGilead Sciences, Inc. 1.82%68.161.0%$679.44m
AMGNAmgen, Inc. 1.42%257.101.3%$584.68m
REGNRegeneron Pharmaceuticals, Inc. 1.94%548.202.7%$502.24m
ALXNAlexion Pharmaceuticals, Inc. 1.00%161.322.0%$478.99m
CRSPCRISPR Therapeutics AG -3.85%181.240.6%$478.16m
ILMNIllumina, Inc. 3.63%421.003.5%$442.75m
NVAXNovavax, Inc. 3.53%131.4692.9%$427.52m
VRTXVertex Pharmaceuticals, Inc. 1.57%241.311.9%$385.00m
SRPTSarepta Therapeutics, Inc. -2.17%96.1113.8%$366.91m
BIIBBiogen, Inc. 2.26%275.541.7%$334.24m
BNTXBioNTech SE 2.00%110.610.0%$314.96m
EXASEXACT Sciences Corp. 2.62%153.9319.6%$267.92m
PACBPacific Biosciences of California, Inc. -3.93%35.957.4%$219.94m

Company Profile

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma; and remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Boulder, CO.